Trans fat, aspirin, and ischemic stroke in postmenopausal women

Annals of Neurology

Volumn 72, Issue 5, 2012, Pages 704-715

  Yaemsiri, Sirin ^a   Sen, Souvik ^b   Tinker, Lesley ^c   Rosamond, Wayne ^a   Wassertheil Smoller, Sylvia ^d   He, Ka ^a  

^a IL   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG USE; FAT INTAKE; FEMALE; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; INCIDENCE; LIFESTYLE; NORMAL HUMAN; OBSERVATIONAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOCYTE AGGREGATION;

AGED; ASPIRIN; BRAIN ISCHEMIA; COHORT STUDIES; CONFIDENCE INTERVALS; DIETARY FATS, UNSATURATED; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MIDDLE AGED; OBSERVATION; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STROKE; WOMEN'S HEALTH;

EID: 84871944681     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23555     Document Type: Article

References (28)

1. Mozaffarian D, Aro A, Willett WC,. Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr 2009; 63 (suppl 2): S5-S21.
2. He K, Merchant A, Rimm EB, et al. Dietary fat intake and risk of stroke in male US healthcare professionals: 14 year prospective cohort study. BMJ 2003; 327: 777-782.
3. Iso H, Stampfer MJ, Manson JE, et al. Prospective study of fat and protein intake and risk of intraparenchymal hemorrhage in women. Circulation 2001; 103: 856-863. (Pubitemid 32163885)
4. He K, Xu Y, Van Horn L,. The puzzle of dietary fat intake and risk of ischemic stroke: A brief review of epidemiologic data. J Am Diet Assoc 2007; 107: 287-295. (Pubitemid 46136126)
5. Renaud SC,. Diet and stroke. J Nutr Health Aging 2001; 5: 167-172. (Pubitemid 32678488)
6. Sauvaget C, Nagano J, Hayashi M, Yamada M,. Animal protein, animal fat, and cholesterol intakes and risk of cerebral infarction mortality in the adult health study. Stroke 2004; 35: 1531-1537. (Pubitemid 38823618)
7. Berger JS, Roncaglioni MC, Avanzini F, et al. Aspirin for the primary prevention of cardiovascular events in women and men: A sex-specific meta-analysis of randomized controlled trials. JAMA 2006; 295: 306-313.
8. Patterson RE, Kristal AR, Tinker LF, et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol 1999; 9: 178-187. (Pubitemid 29144458)
9. Howard BV, Van Horn L, Hsia J, et al. Low-fat dietary pattern and risk of cardiovascular disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006; 295: 655-666. (Pubitemid 43209067)
10. Curb JD, McTiernan A, Heckbert SR, et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 2003; 13: S122-S128. (Pubitemid 37324181)
11. Chen JC, Brunner RL, Ren H, et al. Sleep duration and risk of ischemic stroke in postmenopausal women. Stroke 2008; 39: 3185-3192.
12. Goldstein LB, Jones MR, Matchar DB, et al. Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Stroke 2001; 32: 1091-1098.
13. Willett WC, Howe GR, Kushi LH,. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997; 65: 1220S-1228S; discussion 1229S-1231S. (Pubitemid 27152591)
14. Becker DM, Segal J, Vaidya D, et al. Sex differences in platelet reactivity and response to low-dose aspirin therapy. JAMA 2006; 295: 1420-1427.
15. Meade TW, Vickers MV, Thompson SG, et al. Epidemiological characteristics of platelet aggregability. Br Med J (Clin Res Ed) 1985; 290: 428-432. (Pubitemid 15080970)
16. Tilvis RS, Erkinjuntti T, Sulkava R, et al. Serum lipids and fatty acids in ischemic strokes. Am Heart J 1987; 113: 615-619. (Pubitemid 17026651)
17. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979. (Pubitemid 27152782)
18. Vinikoor LC, Schroeder JC, Millikan RC, et al. Consumption of trans-fatty acid and its association with colorectal adenomas. Am J Epidemiol 2008; 168: 289-297. (Pubitemid 352019782)
19. Chavarro JE, Stampfer MJ, Campos H, et al. A prospective study of trans-fatty acid levels in blood and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 95-101. (Pubitemid 351196278)
20. Goldstein LB, Adams R, Alberts MJ, et al. Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2006; 113: e873-e923. (Pubitemid 44313581)
21. Tirschwell DL, Smith NL, Heckbert SR, et al. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 2004; 63: 1868-1875. (Pubitemid 39532383)
22. Corvol JC, Bouzamondo A, Sirol M, et al. Differential effects of lipid-lowering therapies on stroke prevention: A meta-analysis of randomized trials. Arch Intern Med 2003; 163: 669-676. (Pubitemid 36343359)
23. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet 1995; 346: 1647-1653.
24. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
25. Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial. Lancet 2003; 361: 1149-1158. (Pubitemid 36398384)
26. Di Napoli P, Taccardi AA, Oliver M, De Caterina R,. Statins and stroke: evidence for cholesterol-independent effects. Eur Heart J 2002; 23: 1908-1921. (Pubitemid 35448549)
27. Taylor F, Ward K, Moore TH, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2011;(1): CD004816.
28. Iso H, Sato S, Umemura U, et al. Linoleic acid, other fatty acids, and the risk of stroke. Stroke 2002; 33: 2086-2093. (Pubitemid 34840073)